32 studies found for:    HIV [CONDITION] AND (pregnancy OR perinatal) [TREATMENT] | Open Studies
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Development of Resistance Mutations in Pregnant HIV-Positive (+) Women Following Perinatal Antiretroviral Therapy in Israel
Condition: HIV Infections
Intervention:
2 Recruiting Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Any Antiretroviral Therapy
3 Recruiting Internet-Based Sexual Health Education for Middle School Native American Youth
Conditions: Sexually Transmitted Diseases;   Pregnancy;   HIV Infections
Interventions: Behavioral: HIV, STI and Pregnancy Prevention Curriculum;   Behavioral: Control Curricula
4 Recruiting Evaluation of Raltegravir During the Third Trimester of Pregnancy
Conditions: HIV-1 Infection;   PREGNANCY
Intervention: Other: Study of pharmacokinetic properties of raltegravir during the 3rd trimester of pregnancy
5 Recruiting Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2)
Conditions: Malaria;   Human Immunodeficiency Virus
Interventions: Drug: Monthly dihydroartemisinin-piperaquine (DP) for adult women during pregnancy;   Drug: Monthly dihydroartemisinin-piperaquine (DP) for infants
6 Recruiting Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.
Conditions: HIV Infections;   Hepatitis B
Intervention:
7 Recruiting A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication
Condition: HIV Infection
Intervention:
8 Recruiting Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection
Conditions: HIV;   Pregnancy
Interventions: Drug: Raltegravir;   Drug: Lopinavir/Ritonavir
9 Not yet recruiting Option B+: Study on Safety, Viral Suppression, and Survival on Second Line ART
Conditions: HIV;   Infant Exposure to Efavirenz
Intervention:
10 Recruiting Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Condition: HIV Infections
Interventions: Drug: Current ARV medications;   Drug: Current TB medications;   Drug: Current hormonal contraceptive medications
11 Unknown  Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women
Conditions: HIV Infection;   Pregnancy
Intervention:
12 Recruiting Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV
Conditions: HIV;   Hepatitis B
Interventions: Drug: Tenofovir/lamivudine/lopinavir-ritonavir;   Drug: Zidovudine/lamivudine/lopinavir-ritonavir
13 Recruiting Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
Condition: HIV Infections
Intervention:
14 Recruiting Early ART Initiation Among HIV-positive Pregnant Women in Central Mozambique
Condition: HIV
Intervention: Other: Adherence and retention package
15 Recruiting Evaluating the Response to Three Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Lopinavir/ritonavir;   Drug: Efavirenz;   Drug: Raltegravir
16 Unknown  Preventing Health Damaging Behaviors in Male and Female Army Recruits
Conditions: Sexually Transmitted Infection (STI) Prevention;   Unintended Pregnancy Prevention;   Sexual Risk Reduction;   Alcohol and Other Substance Use Prevention;   Intimate Partner Violence Prevention
Intervention: Behavioral: Staying Safe & In Control: Increasing Knowledge and Building Skills to Prevent STIs and Unintended Pregnancy
17 Recruiting EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)
Condition: Pregnancy Related
Intervention:
18 Recruiting A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women
Conditions: HIV;   HIV Infections;   Pregnancy
Interventions: Drug: Darunavir;   Drug: Ritonavir;   Drug: Etravirine;   Drug: Rilpivirine;   Drug: Darunavir/Cobicistat (FDC)
19 Recruiting Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)
Condition: HIV/AIDS
Intervention:
20 Not yet recruiting The Health Check-Up for Expectant Moms
Condition: HIV
Intervention: Behavioral: Health Check-Up for Expectant Moms

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Indicates status has not been verified in more than two years